cardiologylast update: 11/04/07

back to Golden Hour

  • Diagnosis and Management of Diastolic Dysfunction and Heart Failure ***** new!!!

  • Pharmacologic Cardioversion for Atrial Fibrillation and Flutter - Cochrane for Clinicians *****

  • Acute coronary syndromes - Symposium *****

  • How strong is the evidence for the use of perioperative blockers in non-cardiac surgery? *****

  • Identifying and Treating Patients at High Risk for Heart Failure (acrobat reader) *****

  • Does coronary revascularization before major vascular surgery decrease mortality? *****

  • How Common Is Diastolic Dysfunction Among the Elderly with Dyspnea? (acrobat reader) *****

  • Intensive lipid-lowering therapy *****

  • Ximelagatran vs Warfarin *****

  • Cardiac Resynchronization Therapy for Treatment of Congestive Heart Failure (acrobat reader) *****

  • Update in Cardiology (acrobat reader) *****

  • Pulmonary arterial hypertension: newer treatments are improving outcomes *****

  • Aspirin vs. Plavix after upper GI bleeding *****

  • Coronary revascularization before vascular surgery *****

  • Recent developments in non-invasive cardiology *****

  • Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions *****

  • Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension *****

  • Drug eluting stents and late thrombosis ****

  • Traffic as a trigger for MI ****

  • Cardiovascular risk beyond LDL-C levels ****

  • Discharge planning for CHF *****

  • Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes *****

  • Clopidogrel or Aspirin to Prevent Recurrent Cardiovascular Events? (acrobat reader) *****

  • Outcomes-Based Practice: Heart Murmur in a Child (acrobat reader) ****

  • A Validated Prediction Model for All Forms of Acute Coronary Syndrome *****

  • Screening for Coronary Heart Disease: Recommendation Statement *****

  • When should we treat isolated high triglycerides? *****

  • Angioplasters and thrombolysers *****

  • Ximelagatran effective in preventing stroke in a nonvalvular atrial fibrillation.(Practice Recommendations from Key Studies) *****

  • Raised cardiac troponins - Causes extend beyond acute coronary syndromes *****

  • Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease: A Randomized Trial *****

  • Selective COX-2 Inhibitors and Risk of Cardiovascular Events ***** (acrobat reader)

  • Should patients with severely impaired left ventricular function following myocardial infarction receive an implantable defibrillator? *****

  • Getting better - Myocardial Infarction *****

  • Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea *****

  • Prolonged antithrombotics do not improve unstable coronary syndrome *****

  • Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: A randomized, digoxin-controlled trial *****

  • Surgery in asymptomatic aortic stenosis *****

  • Digitalis for Treatment of Congestive Heart Failure in Patients in Sinus Rhythm *****

  • Indirect comparison meta-analysis of aspirin therapy after coronary surgery *****

  • Coronary heart disease prevention: insights from modelling incremental cost effectiveness *****

  • Drug-Eluting Intra-Coronary Stents: Have We Got the Magic Bullet? *****

  • FDA Advises Physicians of Adverse Events Associated with Cordis Cypher Coronary Stents *****

  • Drug-delivering coronary artery stents: bare metal threatened by extinction? *****

  • Do Antioxidants Prevent Heart Disease? *****

  • Smoking with coronary heart disease - NNTs ****

  • Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial ****

  • Folic Acid Does Not Reduce Cardiovascular Events in Patients with Coronary Artery Disease ****

  • CYPHER coronary stents and risk of thrombosis *****

  • Interventional paediatric cardiology *****

  • Implantable devices for treating tachyarrhythmias *****

  • Percutaneous interventional electrophysiology *****

  • New developments in percutaneous coronary intervention *****

  • Interventional pharmacotherapy *****

  • A cure for cardiovascular disease? ****

  • Acute coronary syndrome: ST segment elevation myocardial infarction *****

  • Perioperative Cardiac Assessment for Noncardiac Surgery *****

  • Aspirin and Clopidogrel in Acute Coronary Syndromes *****

  • Chronic stable angina: treatment options *****

  • A Comparison of On-Pump and Off-Pump Coronary Bypass Surgery in Low-Risk Patients *****

  • Treatment of Uncomplicated Hypertension: Are ACE Inhibitors and Calcium Channel Blockers as Effective as Diuretics and B-Blockers? *****

  • Heart failure - A three-article symposium *****

  • Complicated Left-Sided Native Valve Endocarditis in Adults *****

  • Simvastatin reduced mortality and vascular events *****

  • Systolic blood pressure predicts heart failure best *****

  • Implantable Cardioverter Defibrillators in Primary and Secondary Prevention: A Systematic Review of Randomized, Controlled Trials *****

  • Plasma Homocysteine and Risk for Congestive Heart Failure in Adults Without Prior Myocardial Infarction *****

  • Primary prevention with aspirin *****

  • Homocysteine-lowering therapy improved outcomes after percutaneous coronary intervention *****

  • Clinical significance of cardiovascular dysmetabolic syndrome *****

  • Management of Atrial Fibrillation (acrobat reader) *****

  • Advanced Cardiac Life Support Algorithms: Changes and Current American Heart Association Recommendations (acrobat reader) *****

  • The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) *****

  • Acute intervention has no effect on mortality in patients with acute coronary syndromes *****

  • Antithrombotic strategies in acute coronary syndromes and percutaneous coronary interventions *****

  • Antithrombotic therapy in acute coronary syndromes *****

  • Antithrombotic therapy - Valvar heart disease and prosthetic heart valves *****

  • Homocysteine lowering after percutaneous coronary intervention *****

  • Oral glycoprotein IIb/IIIa inhibitors increase mortality and myocardial infarction *****

  • Diagnosis of infective endocarditis ****

  • An overview of antithrombotic therapy *****

  • Primary percutaneous coronary intervention was more effective than thrombolytic therapy for acute MI *****

  • Estrogen plus progestin increased coronary heart disease and breast cancer events in postmenopausal women *****

  • Acute coronary syndromes - A three-article symposium ****

  • Therapy for cardiovascular disease in patients with chronic kidney disease: Appropriate caution or the absence of data ****

  • Acute Management of Atrial Fibrillation: Rate and Rhythm Control ****

  • Should We Use Multiple Risk Factor Interventions for the Primary Prevention of Coronary Heart Disease? *****

  • Bypass Surgery Versus Stenting for the Treatment of Multivessel Disease in Patients With Unstable Angina Compared With Stable Angina *****

  • Glycoprotein IIb/IIIa inhibitors reduced death or MI in acute coronary syndromes not routinely scheduled for revascularization *****

  • An early invasive strategy was effective in the acute coronary syndrome with elevated cardiac troponin I and T levels *****

  • Paediatric electrocardiography ****

  • Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial *****

  • Prophylactic Implantation of a Defibrillator in Patients With Myocardial Infarction and Reduced Ejection Fraction *****

  • Primary Percutaneous Coronary Intervention for All? *****

  • Early intervention in massive pulmonary embolism *****

  • Stents and thrombosis *****

  • Platelet glycoprotein IIb/IIIa blockers for PCI or acute coronary syndromes reduce death and MI but increase bleeding *****

  • Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure ****

  • How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial *****

  • Abciximab was more effective than tirofiban in preventing ischemic events in patients having coronary stenting *****

  • Cardiopulmonary Resuscitation: Current Status (acrobat reader) ****

  • Initial antihypertensive therapy ****

  • Genetics and cardiovascular risk - Clinical review ****

  • Carvedilol reduced mortality and hospitalization in severe chronic heart failure *****

  • Surgery for Chronic Aortic Regurgitation: When Should It Be Considered? ****

  • Reducing Ischemic Events in Acute Coronary Syndrome *****

  • Troponin tests for cardiac damage *****

  • What is the value of screening for heart disease with an exercise stress test (EST) in an asymptomatic person? *****

  • Should patients with unstable coronary syndromes routinely undergo cardiac catheterization ? *****

  • Guideline for the Management of Heart Failure Caused by Systolic Dysfunction: Part II. Treatment *****

  • Guideline for the Management of Heart Failure Caused by Systolic Dysfunction: Part Part I. Etiology and Diagnosis *****

  • Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension ****

  • Risk of stroke with AF - A clinical scoring system *****

  • Early Invasive VS Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor *****

  • Effect of Carvedilol on Survival in Severe Chronic Heart Failure *****

  • Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation *****

  • New Approaches to Pulmonary Hypertension ****

  • Current management of chronic heart failure *****

  • Aspirin for primary prevention of coronary heart disease ****

  • Antioxidant supplements to prevent heart disease ****

  • Endoluminal Beta-Radiation Therapy for the Prevention of Coronary Restenosis after Balloon Angioplasty ****

  • Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset AF to sinus rhythm ? *****new!!!

  • Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis *****

  • The Pathogenesis of Acute Pulmonary Edema Associated with Hypertension *****

  • Costs of Revascularization Over Eight Years in the Randomized and Eligible Patients in the Emory Angioplasty Versus Surgery Trial (EAST) *****

  • Treatment possibilities for unstable angina ****

  • Single dose amiodarone for atrial fibrillation *****

  • Optimizing Beta-Blocker Use After Myocardial Infarction ****

  • Review: Thienopyridines are more effective than aspirin for preventing vascular events in high-risk patients *****

  • Predictors of Outcome in Severe, Asymptomatic Aortic Stenosis ****

  • Cardiovascular Screening of Student Athletes ****

  • A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus Arteriosus *****

  • Cardioprotective value of aspirin in primary prevention is greater the lower the blood pressure *****

  • Primary Angioplasty—Time Is of the Essence *****

  • Dalteparin reduced death and MI at 1 but not 3 months in unstable coronary artery disease managed noninvasively *****

  • Cardiopulmonary Resuscitation by Chest Compression Alone or with Mouth-to-Mouth Ventilation *****

  • Pleural effusions in cardiovascular disease ****

  • AHA and ACC Outline Approaches to Coronary Disease Risk Assessment - Practice Guidelines *****

  • Best treatment for single-vessel coronary artery disease *****

  • Cardiac Syndrome X: An Overview ****

  • Compiling the identifying features of bacterial endocarditis ****

  • Sex Bias in Cardiovascular Care - Should Women Be Treated More Like Men? *****

  • Abciximab and stenting reduced death, myocardial infarction, and repeated revascularization in coronary revascularization *****

  • Contemporary Management of Angina: Part I. Risk Assessment ****

  • Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients *****

  • Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction ****

  • The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure *****

  • Cardiac Arrhythmia: Current Therapy****

  • Percutaneous Transluminal Myocardial Revascularization*****

  • Management of acute myocardial infarction*****

  • Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock *****

  • Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia*****

  • Effective management of complex heart failure ****

  • Prevalence and Clinical Outcome of Mitral-Valve Prolapse ****

  • Maximizing the exercise stress test ****

  • Evidence based cardiology-Prevention of ischaemic stroke *****

  • Reducing the risk of recurrent coronary heart disease ****

  • Replacement of the Aortic Root in Patients with Marfan's Syndrome *****

  • Intracoronary stents *****

  • Warfarin Therapy: Evolving Strategies in Anticoagulation ****

  • Ordering and Understanding the Exercise Stress Test *****

  • A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure ****

  • Enoxaparin or unfractionated Heparin for acute coronary syndrome *****

  • Carvedilol: The New Role of Beta Blockers in Congestive Heart Failure *****

  • Amiodarone reduces mortality after MI and for congestive heart failure ****

  • Indications for Anticoagulation in Atrial Fibrillation****

  • Preventing Congestive Heart Failure*****


    back to Golden Hour

    Subscribe to our free monthly email newsletter "Golden-News" with hundreds of subscribers worldwide. Place your full email address in the blank below and click on the "subscribe".
    We respect the privacy of our subscribers.


    homeabout usabout the sitead. policywrite us